New patent for Glaxosmithkline drug TRELEGY ELLIPTA
Annual Drug Patent Expirations for TRELEGY+ELLIPTA Trelegy Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are nineteen patents…
The post New patent for Glaxosmithkline drug TRELEGY ELL…
New patent for Glaxosmithkline drug TRELEGY ELLIPTA Read Post »